CorePlus Puerto Rico Publishes Groundbreaking Study on Implementing 100% Quality Control in Cervical Cytology Using Whole Slide Imaging and Artificial Intelligence
Revolutionizing Cytology with AI and Digital Pathology
As digital pathology continues to advance into the field of cytopathology, laboratories are exploring alternatives to traditional manual microscopy screening. CorePlus evaluated the performance of the Techcyte SureView™ system—specifically designed for digital cytopathology—on 1,442 digitized slides from ThinPrep® and SurePath™ cervical cytology samples.
The slides were scanned using the 3DHISTECH P1000 DX scanner under both dry and water immersion scanning profiles. A board-certified cytopathologist reviewed AI-identified objects of interest and compared them to results obtained through traditional light microscopy.
Outstanding Results and Operational Efficiency
The study demonstrated that the SureView™ system using the water immersion profile significantly outperformed both dry scanning and manual microscopy in detecting squamous and glandular abnormalities. Key performance metrics included:
97% accuracy
82% sensitivity
99% specificity
98% negative predictive value
86% positive predictive value
In addition to its high diagnostic performance, the AI-assisted system considerably reduced review times and improved overall workflow efficiency.
A New Standard for Quality Control in Cervical Cytology
Following successful validation, CorePlus has fully integrated the Techcyte SureView™ system as a 100% QC tool in its laboratory operations. This marks a major step forward in adopting digital and AI technologies to enhance diagnostic accuracy, laboratory efficiency, and patient care.
'We have been able to achieve an unprecedented level of consistency and confidence in cervical cytology screening, every PAP Counts!' Mariano de Socarraz, Founder and Chief Executive Officer at CorePlus. 'Our team is proud to contribute to the advancement of digital pathology and demonstrate its real-world clinical impact.'
For access to the complete published study please visit: Implementing 100% quality control in a cervical cytology workflow using whole slide images and artificial intelligence provided by the Techcyte SureView™ System – Rivera Rolon – 2025 – Cancer Cytopathology – Wiley Online Library
About CorePlus
CorePlus is a state-of-the-art precision pathology organization based in Puerto Rico, committed to diagnostic excellence through innovation and technology. With a patient-centered approach and quality-driven processes, CorePlus is at the forefront of adopting artificial intelligence algorithms as decision support tools for our pathologists offering unprecedented accuracy and efficiency.
About Cancer Cytopathology
Cancer Cytopathology is a peer-reviewed medical journal published by the American Cancer Society. Internationally recognized, it focuses on the science and practice of cancer cytopathology. The journal publishes innovative research, clinical studies, and expert reviews aimed at improving diagnostic accuracy and outcomes in cancer management. The publication of the CorePlus study in Cancer Cytopathology highlights its significant contribution to the advancement of digital cytopathology in cancer diagnostics and quality control.
About Techcyte
Founded in 2013, Techcyte is transforming the practice of pathology with a unified pathology platform that digitizes lab workflows and offers AI tools that improve the efficiency and accuracy of diagnostic testing.
Our mission is to positively impact the health of humans, animals, and the environment through the use of artificial intelligence.
We do that by partnering with best-in-class labs, whole slide scanner manufacturers, AI vendors, diagnostic companies, hardware manufacturers, and solution providers. Together, we aim to deliver a unified clinical and anatomic pathology platform to labs and clinics around the world.
Visit www.techcyte.com for more information.
About Epredia
Epredia, a global leader in precision cancer diagnostics and subsidiary of PHC Holdings Corporation (TSE: 6523) offers a unique array of end-to-end instruments for pathology workflows including tissue processors, microtomes, embedding stations, and a range of 3DHistech developed whole slide scanners from the single slide Pannoramic Desk II to the Pannoramic 1000 scanner. These scanners offer a single slide to 1000 slide capacity and a throughput of up to 85 slides per hour, including overnight scanning.
Visit www.epredia.com for more information.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Malaysian Reserve
15 minutes ago
- Malaysian Reserve
Antengene Announces Poster Presentation of ATG-022 (Claudin 18.2 ADC) at ESMO 2025
SHANGHAI and HONG KONG, July 28, 2025 /PRNewswire/ — Antengene Corporation Limited ('Antengene', SEHK: a leading innovative, commercial-stage global biopharmaceutical company dedicated to discovering, developing and commercialising first-in-class and/or best-in-class medicines for cancer, today announced that an abstract featuring the latest data from a Phase I/II study of the Claudin 18.2 antibody-drug conjugate (ADC), ATG-022, has been accepted for poster presentation at the 2025 European Society for Medical Oncology Annual Congress (ESMO 2025), taking place from October 17th to October 21st at the Messe Berlin in Berlin, Germany. Details of the Poster Presentation: ATG-022 (Claudin 18.2 antibody-drug conjugate)Title: Phase I/II study of Claudin 18.2 ADC ATG-022 in patients with advanced gastric/ gastroesophageal junction cancer (CLINCH)Abstract Number: 2907Presentation Number: 2113PDate: October 19, 2025 About ATG-022 ATG-022 is an antibody-drug conjugate (ADC) designed to target CLDN18.2, a member of the Claudin family of cell adhesion molecules. Under normal conditions, Claudins are located within tight junctions between cells, forming a barrier to regulate cell permeability. However, in cancer, Claudins are aberrantly expressed on the cell surface due to changes in cell polarity. CLDN18.2 is frequently overexpressed in a range of primary malignant tumors, including gastric, esophageal, cholangiocarcinoma, and pancreatic cancers. The U.S. Food and Drug Administration (FDA) has awarded Orphan Drug Designations to ATG-022, for gastric and pancreatic cancers. Data from the ongoing CLINCH study demonstrated that ATG-022 delivers robust efficacy across all levels of CLDN18.2 expression in gastric cancer patients, including those with high, low, and ultra-low expression. This broad activity positions ATG-022 as a potential market leader, capable of addressing the largest patient population with CLDN18.2-positive tumors. Furthermore, the strong efficacy observed in patients with low CLDN18.2 expression suggests promise for treating other tumor types with similar expression profiles. About Antengene Antengene Corporation Limited ('Antengene', SEHK: is a leading commercial-stage R&D-driven global biopharmaceutical company focused on the discovery, development, manufacturing and commercialization of innovative first-in-class/best-in-class therapeutics for the treatment of hematologic malignancies and solid tumors, in realizing its vision of 'Treating Patients Beyond Borders'. Antengene has built a pipeline of 9 oncology assets at various stages going from clinical to commercial, including 6 with global rights, and 3 with rights for the APAC region. To date, Antengene has obtained 31 investigational new drug (IND) approvals in the U.S. and Asia, and submitted new drug applications (NDAs) in 11 Asia Pacific markets, with the NDA for XPOVIO® (selinexor) already approved in Mainland of China, Taiwan China, Hong Kong China, Macau China, South Korea, Singapore, Malaysia, Thailand, Indonesia and Australia. Forward-looking statements The forward-looking statements made in this article relate only to the events or information as of the date on which the statements are made in this article. Except as required by law, we undertake no obligation to update or revise publicly any forward-looking statements, whether as a result of new information, future events or otherwise, after the date on which the statements are made or to reflect the occurrence of unanticipated events. You should read this article completely and with the understanding that our actual future results or performance may be materially different from what we expect. In this article, statements of, or references to, our intentions or those of any of our Directors or our Company are made as of the date of this article. Any of these intentions may alter in light of future development. For a further discussion of these and other factors that could cause future results to differ materially from any forward-looking statement, please see the other risks and uncertainties described in the Company's Annual Report for the year ended December 31, 2024, and the documents subsequently submitted to the Hong Kong Stock Exchange. For more information, please contact: Investor Contacts: Donald LungE-mail: Mobile: +86 18420672158 PR Contacts:Peter QianE-mail: Mobile: +86 13062747000
Malaysian Reserve
2 hours ago
- Malaysian Reserve
Bossjob Launches in Malaysia: A Smarter Way to Find Jobs through Chat-first AI Matching
KUALA LUMPUR, Malaysia, July 28, 2025 /PRNewswire/ — Bossjob, Southeast Asia's chat-based AI job platform, today announced its official launch in Malaysia, bringing job seekers and employers a faster, smarter, more human-centric way to connect. The new job platform in Malaysia aims to transform how Malaysians find work—especially among Gen Z and gig economy workers. Why Malaysia, Why Now? Malaysia is in the middle of a digital shift, driven by its mobile-first, youth-dominated population. As demand for flexible, blue-collar, and entry-level jobs surges, Bossjob steps in with a bold promise: faster hiring, AI-powered matchmaking, and instant communication—right from your phone. But this isn't a pilot—it's a proven formula. Bossjob has already helped over 100 million jobseekers globally, with local operations focused on serving the Philippines, Singapore, Indonesia and Japan. Since 2023, we've seen a 500% increase in monthly active users in the Philippines alone, while becoming the #1 downloaded chat-first job app in the country. Over 10 million messages have been exchanged between jobseekers and employers, with an average response time of under 10 minutes. Most users complete their job applications in less than 90 seconds. Our AI-matching engine delivers real-time, relevant roles—83% of jobseekers receive a match within 24 hours, and 78% are hired within just 7 days of chatting. That's hiring in under a week—without the waiting game. What Makes Bossjob Different? Chat–first hiring – Message employers instantly, eliminating lengthy application forms and long wait times. AI-powered job matching – Our algorithms understand applicant skills, preferences, and chat behavior, delivering relevant job matches in real time. Simplified profile creation – No more juggling CV formats. Our streamlined profile process means users can apply with one tap. 'We are committed to making job searching more accessible and efficient for job seekers,' said Bernie Goh, Country Manager Malaysia of Bossjob. 'Through this campaign, we aim to connect with job seekers on the go, reinforcing our commitment to simplifying the job search process and empowering job seekers with fast and direct access to employers.' Bossjob is already helping businesses move at the speed of chat. 'Bossjob helped us connect quickly and meaningfully with Malaysia's young talent during our KL launch. Unlike traditional platforms, their chat-first model let us engage candidates instantly—speed made all the difference,' said Chevelle Tham, HR Manager & Hiring Lead at Hvala. Available Nationwide Bossjob's mobile app and web platform are now available nationwide. With job locations initially focused on Kuala Lumpur and Johor, jobseekers in Bossjob Malaysia can: Instantly connect with F&B, logistics, retail, and office employers. Discover AI-curated roles suited to their profile. Skip long registration processes; profile setup takes under two minutes. 'Bossjob isn't just offering a new job search alternative in Malaysia—it's equipping jobseekers with the tools and Gen AI technology to optimise their candidate profiles,' Goh added. 'From fresh graduates to seasoned professionals, we believe every jobseeker deserves not only fast access to opportunities, but also the means to present their best self to employers.' Vision for Southeast Asia Bossjob's Malaysia launch is part of its broader mission: to make job hunting instant, equitable, and accessible across the region. With 8,000+ active employers across Southeast Asia—including brands like Jollibee, Lazada, and Uniqlo—we're already trusted by 60% of SMEs in the Philippines and 40% of Singapore's fastest-growing startups. In Japan, we were the first chat-based platform to enter the gig market, achieving over 90% satisfaction in our pilot phase. Get Started Join over 2.5 million users across Southeast Asia who are transforming their job search with Bossjob. With AI-curated roles, real-time chat with employers, and hiring in under a week, it's the fastest way to get hired in the region. Bossjob has facilitated over 5 million job connections in the Philippines, Singapore, and Japan—making us Southeast Asia and Japan's fastest-growing job-matching platform. Bossjob's AI-driven chat engine is redefining job search—delivering relevant jobs in real-time, not weeks. Bossjob is now live in Malaysia. Download our app from the App Store or Google Play—or sign up online and start chatting. Your next job could be one message away. About Bossjob Bossjob is a chat-first, AI-powered job platform transforming hiring across Blue-collar, gig, and Gen Z sectors. With over 1 million downloads and thousands of successful connections in SEA, Bossjob is on a mission to reinvent job search—one chat at a time.
Malaysian Reserve
a day ago
- Malaysian Reserve
5th China New E-commerce Conference Opens in Yanbian, Jilin Province
YANJI, China, July 27, 2025 /PRNewswire/ — This is a news release from The 5th China New E-commerce Conference opened today in Yanbian, Jilin Province, aiming to deepen public-private dialogue and drive the continued evolution of the country's digital commerce sector. The event is hosted by the China Federation of Internet Societies and co-organized by the China International Electronic Commerce Center, the Publicity Department of the CPC Jilin Provincial Committee, the Cyberspace Administration of Jilin Province, the Jilin Provincial Department of Commerce, and the People's Government of Yanbian Korean Autonomous Prefecture, with additional support from the China Chamber of International Commerce. Positioned as a high-level platform for engagement between government regulators and industry leaders, the conference reflects the growing role of emerging e-commerce platforms in shaping digital innovation and corporate social responsibility. It also highlights efforts to promote regional alignment, resource integration, and sustainable digital economic growth. Held under the theme 'A New Era of Digital intelligence, A New Value for E-commerce,' the program features an opening ceremony, main forum, sub-forums, specialized breakout sessions, and a series of satellite events. Among the highlights were policy briefings and keynote addresses from senior government officials and industry executives, the release of the China New E-commerce Development Report (2025), and the presentation of new case studies documenting innovation across the e-commerce sector. Organizers also introduced the fourth cohort of top-performing livestream hosts as part of the ongoing Talent Development Program and formally launched the Empowering Premium Hosts Initiative. The event additionally marked the rollout of two new initiatives: the Integrated Cross-border Exhibition and Sales Project and the High-quality Development Campaign for New E-commerce. Four thematic sub-forums focused on technological innovation, integrated development, cross-border e-commerce, and sustainability and corporate responsibility. Two featured events—the industry chain matchmaking and exhibition showcase, and a dedicated session on the ginseng industry—offered insight into key regional and vertical strengths. In parallel, a slate of related activities was held, including the High-quality Development Campaign for New E-commerce, the national finals of the China E-commerce Host Competition—which emphasized revitalization efforts in China's border regions through health and wellness—and continued programming under the Empowering Premium Hosts Initiative. Collectively, these efforts aim to translate the conference's agenda into practical outcomes and unlock further growth across the broader e-commerce ecosystem.
